Serveur d'exploration sur l'Indium - Corpus (Accueil)

Index « MedMesh.i » - entrée « Neoplasm Metastasis »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Neoplasm Invasiveness < Neoplasm Metastasis < Neoplasm Proteins  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 186.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000A84 (2012) Visualisation of sentinel lymph node with indium-based near infrared emitting Quantum Dots in a murine metastatic breast cancer model.
000B82 (2012) Somatostatin receptor scintigraphy with 111In-octreotide in pulmonary carcinoid tumours correlated with pathological and 18FDG PET/CT findings.
000C22 (2012) Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement.
000D18 (2012) Specific binding and uptake of 131I-MIBG and 111In-octreotide in metastatic paraganglioma--tools for choice of radionuclide therapy.
000D71 (2012) Multimodal interventional molecular imaging of tumor margins and distant metastases by targeting αvβ3 integrin.
000E51 (2012) Pretargeted radioimmunotherapy (pRAIT) in medullary thyroid cancer (MTC).
001013 (2012) (111)In-octreotide scintigraphy for identification of metastatic medullary thyroid carcinoma in children and adolescents.
001134 (2011) Intra-arterial treatment with 90yttrium microspheres in treatment-refractory and unresectable liver metastases of neuroendocrine tumors and the use of 111in-octreotide scintigraphy in the evaluation of treatment response.
001171 (2011) Diagnostic performance of In-111 capromab pendetide SPECT/CT in localized and metastatic prostate cancer.
001199 (2011) Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours.
001384 (2011) Altered biodistribution of somatostatin analogues after first cycle of Peptide receptor radionuclide therapy.
001490 (2011) VEGF-SPECT with ¹¹¹In-bevacizumab in stage III/IV melanoma patients.
001605 (2011) Imaging agents for in vivo molecular profiling of disseminated prostate cancer--targeting EGFR receptors in prostate cancer: comparison of cellular processing of [111In]-labeled affibody molecule Z(EGFR:2377) and cetuximab.
001929 (2010) Metastatic rectal carcinoid on In-111 octreotide SPECT-CT imaging.
001B56 (2009) Radionuclide imaging of tumor angiogenesis.
001B73 (2010) Systemic therapy for neuroendocrine tumours of gastroenteropancreatic origin.
001C82 (2010) Value of 123I-MIBG Scintigraphy in Paraganglioma.
001D10 (2009) (68)Ga-DOTA-TOC/NOC in bronchial carcinoids.
001E61 (2009) Predictive value of 18F-FDG PET and somatostatin receptor scintigraphy in patients with metastatic endocrine tumors.
001F44 (2009) Neuroendocrine differentiated breast carcinoma with pleural metastases using indium-111 octreotide.
001F51 (2009) Metastatic melanoma imaging with an (111)In-labeled lactam bridge-cyclized alpha-melanocyte-stimulating hormone peptide.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV2/Data/Main/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/MedMesh.i -k "Neoplasm Metastasis" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/MedMesh.i  \
                -Sk "Neoplasm Metastasis" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV2
   |flux=    Main
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Neoplasm Metastasis
}}

Wicri

This area was generated with Dilib version V0.5.76.
Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024